Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America

References

• Agodi A, Barchitta M, Cipresso R, et al. (2007). Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med 33:1155–61
   PubMed Web of Science ®Google Scholar
• Antonio CS, Neves PR, Medeiros M, et al. (2011). High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals. Antimicrob Agents Chemother 55:1322–3
   PubMed Web of Science ®Google Scholar
• Arduino SM, Quiroga MP, Ramirez MS, et al. (2012). Transposons and integrons in colistin resistant clones with epidemic or sporadic behavior. J Med Microbiol 61:1417–20
   PubMed Web of Science ®Google Scholar
• Bantar C, Curcio D, Fernandez Canigia L, et al. (2009). Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America. J Chemother 21:144–52
   PubMed Web of Science ®Google Scholar
• Bantar C, Famiglietti A, Radice M, Quinteros M. (2008). A 7-year national survey on bacterial resistance in bronchoalveolar lavage from patients hospitalized in Argentina. Diagn Microbiol Infect Dis 60:65–9
   PubMed Web of Science ®Google Scholar
• Barbolla RE, Centron D, Di Martino A, et al. (2003). Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City. Diagn Microbiol Infect Dis 45:261–4
   PubMed Web of Science ®Google Scholar
• Barbolla RE, Centron D, Maimone S, et al. (2008). Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control 36:444–52
   PubMed Web of Science ®Google Scholar
• Bergen PJ, Landersdorfer CB, Lee HJ, et al. (2012). ‘Old’ antibiotics for emerging multidrug-resistant bacteria. Curr Opin Infect Dis 25:626–33
   PubMed Web of Science ®Google Scholar
• Bertrand X, Dowzicky MJ. (2012). Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther 34:124–37
   PubMed Web of Science ®Google Scholar
• Bonomo RA, Szabo D. (2006). Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 43:S49–56
   Web of Science ®Google Scholar
• Carneiro M, Barbosa PI, Vespero EC, et al. (2010). Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia. Am J Infect Control 38:667–9
   PubMed Web of Science ®Google Scholar
• Carvalho KR, Carvalho-Assef AP, Peirano G, et al. (2009). Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 34:25–8
   PubMed Web of Science ®Google Scholar
• Castelo Branco Fortaleza CM, Moreira de Freitas F, da Paz Lauterbach G. (2013). Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil. Am J Infect Control 41:263–5
   PubMed Web of Science ®Google Scholar
• Cavalcanti FL, Almeida AC, Vilela MA, et al. (2012). Changing the epidemiology of carbapenem-resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of Sao Paulo metallo-beta-lactamase-producing isolates. Memorias do Instituto Oswaldo Cruz 107:420–3
   PubMed Web of Science ®Google Scholar
• Cejas D, Almuzara M, Santella G, et al. (2008). Phenotypic and genotypic characterization of imipenem-resistant Pseudomonas aeruginosa isolated in a Buenos Aires hospital. Revista Argentina de Microbiologia 40:238–45
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2004). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–85
   PubMed Web of Science ®Google Scholar
• Cereda RF, Azevedo HD, Girardello R, et al. (2011). Antimicrobial activity of ceftobiprole against gram-negative and gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study. Braz J Infect Dis 15:339–48
   PubMed Web of Science ®Google Scholar
• Cezario RC, Duarte De Morais L, Ferreira JC, et al. (2009). Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enfermedades Infecciosas y Microbiologia Clinica 27:269–74
   PubMed Web of Science ®Google Scholar
• Cholley P, Gbaguidi-Haore H, Bertrand X, et al. (2010). Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital. J Hospital Infect 76:316–19
   PubMed Web of Science ®Google Scholar
• Cholley P, Thouverez M, Hocquet D, et al. (2011). Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol 49:2578–83
   PubMed Web of Science ®Google Scholar
• Coelho-Souza T, Reis JN, Martins N, et al. (2013). Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil. Clin Microbiol Infect 19:E241–4
   PubMed Web of Science ®Google Scholar
• Coelho J, Woodford N, Afzal-Shah M, Livermore D. (2006). Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 50:756–8
   PubMed Web of Science ®Google Scholar
• Crespo MP, Woodford N, Sinclair A, et al. (2004). Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 42:5094–101
   PubMed Web of Science ®Google Scholar
• Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, et al. (2008). Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Revista Panamericana de Salud Publica 24:16–24
   PubMed Web of Science ®Google Scholar
• Curcio DJ. (2011). Antibiotic prescription in intensive care units in Latin America. Revista Argentina de Microbiologia 43:203–11
   PubMed Web of Science ®Google Scholar
• Dalla-Costa LM, Coelho JM, Souza HA, et al. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 41:3403–6
   PubMed Web of Science ®Google Scholar
• Doi Y, Ghilardi AC, Adams J, et al. (2007). High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil. Antimicrob Agents Chemother 51:3388–90
   PubMed Web of Science ®Google Scholar
• Donald HM, Scaife W, Amyes SG, Young HK. (2000). Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 44:196–9
   PubMed Web of Science ®Google Scholar
• dos Santos Saalfeld SM, Fukita Viana G, Dias Siqueira VL, et al. (2009). Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit. J Hospital Infect 72:365–8
   PubMed Web of Science ®Google Scholar
• Fehlberg LC, Xavier DE, Peraro PP, et al. (2012). Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist 18:402–7
   PubMed Web of Science ®Google Scholar
• Fernandez-Canigia L, Dowzicky MJ. (2012). Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob 11:29
   PubMedGoogle Scholar
• Ferreira AE, Marchetti DP, da Cunha GR, et al. (2011). Molecular characterization of clinical multiresistant isolates of Acinetobacter sp. from hospitals in Porto Alegre, State of Rio Grande do Sul, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 44:725–30
   Google Scholar
• Fica CA, Cespedes JI, Gompertz GM, et al. (2007). [Intravenous colistin in the treatment of infections due to pan-resistant Gram negative bacilli]. Rev Chilena Infectol 24:360–7
   PubMed Web of Science ®Google Scholar
• Figueiredo DQ, Santos KR, Pereira EM, et al. (2011). First report of the bla(OXA-58) gene in a clinical isolate of Acinetobacter baumannii in Rio de Janeiro, Brazil. Memorias do Instituto Oswaldo Cruz 106:368–70
   PubMed Web of Science ®Google Scholar
• Franco MR, Caiaffa-Filho HH, Burattini MN, Rossi F. (2010). Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 65:825–9
   PubMed Web of Science ®Google Scholar
• Freire AT, Melnyk V, Kim MJ, et al. (2010). Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiol Infect Dis 68:140–51
   PubMed Web of Science ®Google Scholar
• Furtado GH, Gales AC, Perdiz LB, et al. (2011). Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa. Revista da Sociedade Brasileira de Medicina Tropical 44:604–6
   PubMed Web of Science ®Google Scholar
• Furtado GH, Perdiz LB, Onita JH, et al. (2010). Correlation between rates of carbapenem consumption and the prevalence of carbapenem-resistant Pseudomonas aeruginosa in a tertiary care hospital in Brazil: a 4-year study. Infect Control Hospital Epidemiol 31:664–6
   PubMed Web of Science ®Google Scholar
• Gales AC, Castanheira M, Jones RN, Sader HS. (2012). Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 73:354–60
   PubMed Web of Science ®Google Scholar
• Gales AC, Jones RN, Sader HS. (2006). Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004). Clin Microbiol Infect 12:315–21
   PubMed Web of Science ®Google Scholar
• Gales AC, Jones RN, Sader HS. (2011). Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 66:2070–4
   PubMed Web of Science ®Google Scholar
• Gales AC, Menezes LC, Silbert S, Sader HS. (2003). Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother 52:699–702
   PubMed Web of Science ®Google Scholar
• Garza-Gonzalez E, Llaca-Diaz JM, Bosques-Padilla FJ, Gonzalez GM. (2010). Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Chemotherapy 56:275–9
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Morfin-Otero R, Sader HS, et al. (2008a). Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother 52:2943–6
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Tinoco P, Silva-Sanchez J, et al. (2008b). Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents 31:78–80
   PubMed Web of Science ®Google Scholar
• Gaynes R, Edwards JR. (2005). Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–54
   PubMed Web of Science ®Google Scholar
• Girardello R, Bispo PJ, Yamanaka TM, Gales AC. (2012). Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol 50:2414–18
   PubMed Web of Science ®Google Scholar
• Goncalves DC, Lima AB, Leao LS, et al. (2009). Detection of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from hospitalized patients in Goiania, State of Goias. Revista da Sociedade Brasileira de Medicina Tropical 42:411–14
   PubMed Web of Science ®Google Scholar
• Grosso F, Carvalho KR, Quinteira S, et al. (2011). OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 66:62–5
   PubMed Web of Science ®Google Scholar
• Guevara A, Sierra RC, de Waard J. (2012). Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa from four hospitals of Venezuela. Rev Chilena Infectol 29:614–21
   PubMed Web of Science ®Google Scholar
• Hart Casares M, Espinosa Rivera F, Halley Posada MC, et al. (2010). Resistance to antibiotics in Acinetobacter baumanii isolated from January to March, 2010. Rev Cubana Med 49:218–27
   Google Scholar
• Hart Casares M, Llanes Rodríguez N, Espinosa Rivera F, et al. (2008). Study of the antimicrobial sensitivity of Acinetobacter baumanii in “Hermanos Ameijeiras” Hospital, year 2006. Rev Cubana Med 47
   Google Scholar
• Herrera ME, Mobilia LN, Posse GR. (2011). Comparative evaluation of the sensitivity of Acinetobacter to colistin, using the prediffusion and minimum inhibitory concentration methods: detection of heteroresistant isolates. Revista Argentina de Microbiologia 43:115–19
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, et al. (2008). NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hospital Epidemiol 29:996–1011
   PubMed Web of Science ®Google Scholar
• Higgins PG, Dammhayn C, Hackel M, Seifert H. (2010). Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65:233–8
   PubMed Web of Science ®Google Scholar
• Higgins PG, Janssen K, Fresen MM, et al. (2012). Molecular epidemiology of Acinetobacter baumannii bloodstream isolates from the United States 1995–2004 using rep-PCR and multilocus sequence typing. J Clin Microbiol 50:3493–500
   PubMed Web of Science ®Google Scholar
• Higgins PG, Perez-Llarena FJ, Zander E, et al. (2013). OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57:2121–6
   PubMed Web of Science ®Google Scholar
• Higgins PG, Poirel L, Lehmann M, et al. (2009). OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53:5035–8
   PubMed Web of Science ®Google Scholar
• Hogardt M, Schmoldt S, Gotzfried M, et al. (2004). Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 54:1057–61
   PubMed Web of Science ®Google Scholar
• Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
   PubMed Web of Science ®Google Scholar
• Jacome PR, Alves LR, Cabral AB, et al. (2012). First report of KPC-producing Pseudomonas aeruginosa in Brazil. Antimicrob Agents Chemother 56:4990
   PubMed Web of Science ®Google Scholar
• Jones ME, Draghi DC, Thornsberry C, et al. (2004). Emerging resistance among bacterial pathogens in the intensive care unit–a European and North American Surveillance study (2000–2002). Ann Clin Microbiol Antimicrob 3:14
   PubMedGoogle Scholar
• Jones RN, Ferraro MJ, Reller LB, et al. (2007). Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45:227–30
   Google Scholar
• Jones RN, Stilwell MG, Rhomberg PR, Sader HS. (2009). Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007). Diagn Microbiol Infect Dis 65:331–4
   PubMed Web of Science ®Google Scholar
• Kayabas U, Bayraktar M, Otlu B, et al. (2008). An outbreak of Pseudomonas aeruginosa because of inadequate disinfection procedures in a urology unit: a pulsed-field gel electrophoresis-based epidemiologic study. Am J Infect Control 36:33–8
   PubMed Web of Science ®Google Scholar
• Kiffer C, Hsiung A, Oplustil C, et al. (2005). Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003. Braz J Infect Dis 9:216–24
   PubMedGoogle Scholar
• Kvitko CH, Rigatto MH, Moro AL, Zavascki AP. (2011). Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 66:175–9
   PubMed Web of Science ®Google Scholar
• Leal AL, Eslava-Schmalbach J, Alvarez C, et al. (2006). Endemic tendencies and bacterial resistance markers in third-level hospitals in Bogota, Colombia. Rev Salud Publica (Bogota) 8:59–70
   PubMedGoogle Scholar
• Lee K, Yong D, Jeong SH, Chong Y. (2011). Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J 52:879–91
   PubMed Web of Science ®Google Scholar
• Llaca-Diaz JM, Mendoza-Olazaran S, Camacho-Ortiz A, et al. (2012). One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico. Chemotherapy 58:475–81
   PubMed Web of Science ®Google Scholar
• Lopes BS, Gallego L, Amyes SG. (2013). Multi-drug resistance profiles and the genetic features of Acinetobacter baumannii isolates from Bolivia. J Infect Dev Ctries 7:323–8
   PubMed Web of Science ®Google Scholar
• Maatallah M, Cheriaa J, Backhrouf A, et al. (2011). Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617
   PubMedGoogle Scholar
• Machado GM, Lago A, Fuentefria SR, Fuentefria DB. (2011). Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil. Revista da Sociedade Brasileira de Medicina Tropical 44:168–72
   PubMed Web of Science ®Google Scholar
• Marais E, de Jong G, Ferraz V, et al. (2004). Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa. Am J Infect Control 32:278–81
   PubMed Web of Science ®Google Scholar
• Marra AR, Camargo LF, Pignatari AC, et al. (2011). Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49:1866–71
   PubMed Web of Science ®Google Scholar
• Marra AR, Pereira CA, Gales AC, et al. (2006). Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother 50:388–90
   PubMed Web of Science ®Google Scholar
• Martins AF, Kuchenbecker R, Sukiennik T, et al. (2009). Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil. Infection 37:474–6
   PubMed Web of Science ®Google Scholar
• Martins AF, Zavascki AP, Gaspareto PB, Barth AL. (2007). Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil. Infection 35:457–60
   PubMed Web of Science ®Google Scholar
• Martins N, Martins IS, de Freitas WV, et al. (2013). Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients. Microb Drug Resist 19:216–23
   PubMed Web of Science ®Google Scholar
• Medell M, Hart M, Marrero O, et al. (2012). Clinical and microbiological characterization of pneumonia in mechanically ventilated patients. Braz J Infect Dis 16:45–51
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Garcia P, et al. (2004). First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 48:1433–4
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Toleman MA, et al. (2007). Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6′)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob Agents Chemother 51:2611–14
   PubMed Web of Science ®Google Scholar
• Mendes RE, Farrell DJ, Sader HS, Jones RN. (2010). Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009). Diagn Microbiol Infect Dis 68:307–11
   PubMed Web of Science ®Google Scholar
• Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. (2010). Acinetobacter baumannii 2002–2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist 16:209–15
   PubMed Web of Science ®Google Scholar
• Merkier AK, Catalano M, Ramirez MS, et al. (2008). Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2:235–40
   PubMed Web of Science ®Google Scholar
• Mezzatesta ML, D'Andrea MM, Migliavacca R, et al. (2012). Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect 18:160–6
   PubMed Web of Science ®Google Scholar
• Moore NM, Flaws ML. (2011). Antimicrobial resistance mechanisms in Pseudomonas aeruginosa. Clin Lab Sci 24:47–51
   PubMedGoogle Scholar
• Moreno CA, Rosenthal VD, Olarte N, et al. (2006). Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hospital Epidemiol 27:349–56
   PubMed Web of Science ®Google Scholar
• Morfin-Otero R, Dowzicky MJ. (2012a). Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009. Clin Ther 34:101–12
   PubMed Web of Science ®Google Scholar
• Morfin-Otero R, Tinoco-Favila JC, Sader HS, et al. (2012b). Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010. BMC Res Notes 5:277
   PubMedGoogle Scholar
• Mussi MA, Limansky AS, Relling V, et al. (2011). Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel. J Bacteriol 193:4736–48
   PubMed Web of Science ®Google Scholar
• Mussi MA, Limansky AS, Viale AM. (2005). Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins. Antimicrob Agents Chemother 49:1432–40
   PubMed Web of Science ®Google Scholar
• Opazo A, Dominguez M, Bello H, et al. (2012). OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries 6:311–16
   PubMed Web of Science ®Google Scholar
• Orecchini LA, Lopez T, Littvik A. (2010). Carbapenems resistance in Pseudomonas aeruginosa during a 10-year period at Rawson Hospital. Revista de la Facultad de Ciencias Medicas / Universidad Nacional de Cordo- a 67:135–40
   Google Scholar
• Pagniez G, Radice M, Cuirolo A, et al. (2006). Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at a university hospital of Buenos Aires City. Revista Argentina de Microbiologia 38:33–7
   PubMedGoogle Scholar
• Pan American Health Organization. Informe anual de la red de Monitoreo/Vigilancia de la resistencia a los antibióticos. Lima, Perú. 3 y 4 de Diciembre, 2009
   Google Scholar
• Pan American Health Organization. Informe anual de la red de Monitoreo/Vigilancia de la resistencia a los antibióticos San José, Costa Rica. 29 noviembre, 1 de diciembre, 2010
   Google Scholar
• Pasteran F, Faccone D, Gomez S, et al. (2012). Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother 67:1291–3
   PubMed Web of Science ®Google Scholar
• Paterson DL. (2006). The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43:S43–8
   PubMed Web of Science ®Google Scholar
• Paton R, Miles RS, Hood J, Amyes SG. (1993). ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2:81–7
   PubMedGoogle Scholar
• Peleg AY, Seifert H, Paterson DL. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538–82
   PubMed Web of Science ®Google Scholar
• Pellegrino FL, Casali N, Nouer SA, et al. (2008). A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene. Diagn Microbiol Infect Dis 61:214–16
   PubMed Web of Science ®Google Scholar
• Pérez IA, Garcia CP, Poggi MH, et al. (2008). Presence of metallo beta-lactamases in imipenem-resistant Pseudomonas aeruginosa. Revista Medica de Chile 136:423–32
   PubMed Web of Science ®Google Scholar
• Picão RC, Poirel L, Gales AC, Nordmann P. (2009). Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother 53:3908–13
   PubMed Web of Science ®Google Scholar
• Poirel L, Marque S, Heritier C, et al. (2005). OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 49:202–8
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12:826–36
   PubMed Web of Science ®Google Scholar
• Polotto M, Casella T, de Lucca Oliveira MG, et al. (2012). Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital. BMC Infect Dis 12:176
   PubMed Web of Science ®Google Scholar
• Pseudomonas Genome Database. Available online at URL: http://www.pseudomonas.com/getAnnotation.do?locusID=PA0958 [last accessed 6 Oct 2013]
   Google Scholar
• Quinones-Falconi F, Galicia-Velasco M, Marchiaro P, et al. (2010). Emergence of Pseudomonas aeruginosa strains producing metallo-beta-lactamases of the IMP-15 and VIM-2 types in Mexico. Clin Microbiol Infect 16:126–31
   PubMed Web of Science ®Google Scholar
• Ramirez J, Dartois N, Gandjini H, et al. (2013). Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia. Antimicrob Agents Chemother 57:1756–62
   PubMed Web of Science ®Google Scholar
• Reinert RR, Low DE, Rossi F, et al. (2007). Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60:1018–29
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Cisneros JM, Fernandez-Cuenca F, et al. (2004). Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hospital Epidemiol 25:819–24
   PubMed Web of Science ®Google Scholar
• Rodriguez CH, Bombicino K, Granados G, et al. (2009). Microbiological and epidemiological evaluation of carbapenem-resistant Acinetobacter baumannii clones isolated at an intensive care unit of a University Hospital in Buenos Aires city. Revista Argentina de Microbiologia 41:151–5
   PubMed Web of Science ®Google Scholar
• Rodriguez CH, De Ambrosio A, Bajuk M, et al. (2010). In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. J Infect Dev Ctries 4:164–7
   PubMed Web of Science ®Google Scholar
• Rosenthal VD, Bijie H, Maki DG, et al. (2012). International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009. Am J Infect Control 40:396–407
   PubMed Web of Science ®Google Scholar
• Rossi F, Garcia P, Ronzon B, et al. (2008). Rates of antimicrobial resistance in Latin America (2004–2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 12:405–15
   PubMed Web of Science ®Google Scholar
• Sader HS, Castanheira M, Mendes RE, et al. (2005a). Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 25:57–61
   PubMed Web of Science ®Google Scholar
• Sader HS, Reis AO, Silbert S, Gales AC. (2005b). IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 11:73–6
   PubMed Web of Science ®Google Scholar
• Salomao R, Rosenthal VD, Grimberg G, et al. (2008). Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Revista Panamericana de Salud Publica 24:195–202
   PubMed Web of Science ®Google Scholar
• Sanchez-Martinez G, Garza-Ramos UJ, Reyna-Flores FL, et al. (2010). In169, a new class 1 integron that encoded bla(IMP-18) in a multidrug-resistant Pseudomonas aeruginosa isolate from Mexico. Arch Med Res 41:235–9
   PubMed Web of Science ®Google Scholar
• Scheffer MC, Bazzo ML, Steindel M, et al. (2010). Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianopolis, Santa Catarina, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 43:367–71
   PubMed Web of Science ®Google Scholar
• Schimith Bier KE, Luiz SO, Scheffer MC, et al. (2010). Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Am J Infect Control 38:308–14
   PubMed Web of Science ®Google Scholar
• Sevillano E, Fernandez E, Bustamante Z, et al. (2012). Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia. J Med Microbiol 61:80–4
   PubMed Web of Science ®Google Scholar
• Silva FM, Carmo MS, Silbert S, Gales AC. (2011a). SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping. Microb Drug Resist 17:215–20
   PubMed Web of Science ®Google Scholar
• Silva FO, Cifuentes M, Pinto EC, en representación del Grupo Colaborativo de Resistencia Antimicrobiana. (2011b). Results of antimicrobial susceptibility surveillance in Chile: consolidating a network. Rev Chile Infect 28:19–27
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Wolfenden LL, Song X, et al. (2003). An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 348:221–7
   PubMed Web of Science ®Google Scholar
• Stietz MS, Ramirez MS, Vilacoba E, et al. (2013). Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 14:294–301
   PubMed Web of Science ®Google Scholar
• Streit JM, Jones RN, Sader HS, Fritsche TR. (2004). Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24:111–18
   PubMed Web of Science ®Google Scholar
• Sykes R. (2010). The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective. J Antimicrob Chemother 65:1842–52
   PubMed Web of Science ®Google Scholar
• Tamber S, Ochs MM, Hancock RE. (2006). Role of the novel OprD family of porins in nutrient uptake in Pseudomonas aeruginosa. J Bacteriol 188:45–54
   PubMed Web of Science ®Google Scholar
• Toledo PV, Arend LN, Pilonetto M, et al. (2012). Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil. J Hospital Infect 80:351–3
   PubMed Web of Science ®Google Scholar
• Toleman MA, Simm AM, Murphy TA, et al. (2002). Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 50:673–9
   PubMed Web of Science ®Google Scholar
• Tuon FF, Gortz LW, Rocha JL. (2012). Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. Braz J Infect Dis 16:351–6
   PubMed Web of Science ®Google Scholar
• Unal S, Garcia-Rodriguez JA. (2005). Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004. Diagn Microbiol Infect Dis 53:265–71
   Google Scholar
• van der Heijden IM, Levin AS, De Pedri EH, Fung L, et al. (2007). Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob 6:8
   PubMedGoogle Scholar
• Viana GF, dos Santos Saalfeld SM, Garcia LB, et al. (2011). Evolution of antimicrobial resistance of Acinetobacter baumannii in a university hospital. Lett Appl Microbiol 53:374–8
   PubMed Web of Science ®Google Scholar
• Vila J, Pachon J. (2012). Therapeutic options for Acinetobacter baumannii infections: an update. Expert Opin Pharmacother 13:2319–36
   PubMed Web of Science ®Google Scholar
• Villagra NA, Fuentes JA, Jofre MR, et al. (2012). The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria. J Antimicrob Chemother 67:921–7
   PubMed Web of Science ®Google Scholar
• Villalobos Rodriguez AP, Diaz Ortega MH, Barrero Garzon LI, et al. (2011). Trends of bacterial resistance phenotypes in high-complexity public and private hospitals in Colombia. Revista Panamericana de Salud Publica 30:627–33
   PubMed Web of Science ®Google Scholar
• Villegas MV, Hartstein AI. (2003). Acinetobacter outbreaks, 1977–2000. Infect Control Hospital Epidemiol 24:284–95
   PubMed Web of Science ®Google Scholar
• Villegas MV, Kattan JN, Correa A, et al. (2007a). Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals. Antimicrob Agents Chemother 51:2001–4
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Correa A, et al. (2007b). First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51:1553–5
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, del Rosario Olivera M, et al. (2006). First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Antimicrob Agents Chemother 50:226–9
   PubMed Web of Science ®Google Scholar
• Vincent JL, Rello J, Marshall J, et al. (2009). International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–9
   PubMed Web of Science ®Google Scholar
• Wang H, Guo P, Sun H, et al. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51:4022–8
   PubMed Web of Science ®Google Scholar
• Werneck JS, Picao RC, Carvalhaes CG, et al. (2011). OXA-72-producing Acinetobacter baumannii in Brazil: a case report. J Antimicrob Chemother 66:452–4
   PubMed Web of Science ®Google Scholar
• Wyeth Pharmaceuticals Inc. (2013). Tygacil (tigecycline) for injection. Wyeth Pharmaceuticals Inc, a subsidiary of Pfizer Inc, Philadelphia, PA. Available from: URL: http://labeling.pfizer.com/showlabeling.aspx?id=491 [last accessed 30 Oct 2013]
   Google Scholar
• Xavier DE, Picao RC, Girardello R, et al. (2010). Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol 10:217
   PubMedGoogle Scholar
• Young LS, Sabel AL, Price CS. (2007). Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hospital Epidemiol 28:1247–54
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Barth AL, Goncalves AL, et al. (2006). The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58:387–92
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Gaspareto PB, Martins AF, et al. (2005). Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 56:1148–51
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Goldani LZ, Goncalves AL, et al. (2007a). High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital. Epidemiol Infect 135:343–5
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Li J, Nation RL, et al. (2009). Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug. J Clin Microbiol 47:3064–5
   Google Scholar
• Zavascki AP, Soares FC, Superti SV, et al. (2007b). Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents 30:187–9
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Chen J, Mody SH, et al. (2010). Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 10:45
   PubMed Web of Science ®Google Scholar